INVESTIGATION OF POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) AS A NOVEL THERAPEUTIC TARGET IN SMALL CELL LUNG CANCER (SCLC)

被引：0
|
作者：
Byers, Lauren A. [1 ]
Nilsson, Monique [1 ]
Fujimoto, Junya [1 ]
Saintigny, Pierre [1 ]
Wang, Jing [1 ]
Diao, Lixia [1 ]
Peyton, Michael [2 ]
Fan, You-Hong [1 ]
Giri, Uma [1 ]
Weber, Stephanie [2 ]
Duchemann, Boris [1 ]
Girard, Luc [2 ]
Coombes, Kevin [1 ]
Weinstein, John [1 ]
Minna, John D. [2 ]
Wistuba, Ignacio [1 ]
Heymach, John V. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
SCLC; PARP1; Large cell neuroendocrine;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1530 / S1531
页数：2
相关论文
共 50 条
  • [41] Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
    Jain, Priyancy G.
    Patel, Bhumika D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 165 : 198 - 215
  • [42] Role of Poly(ADP-ribose) Polymerase 1 (PARP1) in the Modulation of Neutrophil Function: Relevance in Inflammatory Bowel Diseases
    Larmonier, Claire B.
    Shehab, Kareem W.
    McFadden, Rita-Marie T.
    Kiela, Pawel R.
    Ghishan, Fayez K.
    GASTROENTEROLOGY, 2015, 148 (04) : S326 - S327
  • [43] Understanding the role of poly (ADP-ribose) polymerase 1 (PARP-1) activity in prostate cancer
    Cunningham, Moriah
    Evans, Latese
    Tchotorlishvili, Salome
    Gonzalez, Jasibel Vasquez
    Bizzaro, Candice
    Schiewer, Matthew
    CANCER RESEARCH, 2023, 83 (11)
  • [44] Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
    Moroni, Flavio
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 96 - 103
  • [45] Anti-cancer chemosensitization in vitro and in vivo by a novel potent poly(ADP-ribose) polymerase (PARP1) inhibitor, TBI-361.
    Curtin, N
    Barton, S
    Batey, M
    Calabrese, C
    Calvert, H
    Durkacz, B
    Griffin, R
    Golding, B
    Kyle, S
    Newell, D
    Thomas, H
    Wang, L
    Almassy, R
    Boritzki, T
    Canan-Koch, S
    Hostomsky, Z
    Maegley, K
    Webber, S
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3740S - 3740S
  • [46] Proteomic Investigation of Phosphorylation Sites in Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase
    Gagne, Jean-Philippe
    Moreel, Xavier
    Gagne, Pierre
    Labelle, Yves
    Droit, Arnaud
    Chevalier-Pare, Melissa
    Bourassa, Sylvie
    McDonald, Darin
    Hendzel, Michael J.
    Prigent, Claude
    Poirier, Guy G.
    JOURNAL OF PROTEOME RESEARCH, 2009, 8 (02) : 1014 - 1029
  • [47] The Inhibition and Treatment of Breast Cancer with Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors
    De Soto, Joseph A.
    Wang, Xianyan
    Tominaga, Yohei
    Wang, Rui-Hong
    Cao, Liu
    Qiao, Wenhui
    Li, Cuiling
    Xu, Xiaoling
    Skoumbourdis, Amanda P.
    Prindiville, Sheila A.
    Thomas, Craig J.
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2006, 2 (04): : 179 - 185
  • [48] Design, synthesis, and biological evaluation of novel chrysin derivat-ives as poly(ADP-ribose) polymerase 1 (PARP1) inhibitors for the treatment of breast cancer
    Yang, Yao
    Tong, Jing
    Xie, Xianshun
    Cao, Hong
    Fu, Yong
    Luo, Yong
    Liu, Shan
    Chen, Wen
    Yang, Ning
    CHINESE JOURNAL OF NATURAL MEDICINES, 2024, 22 (05) : 455 - 465
  • [49] In-silico designing and synthesis of novel and selective hits as Poly ADP-Ribose Polymerase 1 (PARP1) inhibitors for treatment of solid tumours
    Jain, Priyancy
    Patel, Bhumika
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [50] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 542 - 545
12345